| Balance Sheet of JB Chemicals and Pharmaceuticals (in Rs. Cr.) |
Mar 25 |
Mar 24 |
Mar 23 |
Mar 22 |
Mar 21 |
|
| |
12 mths |
12 mths |
12 mths |
12 mths |
12 mths |
|
| EQUITIES AND LIABILITIES |
|
|
|
|
|
|
| SHAREHOLDER'S FUNDS |
|
|
|
|
|
|
| Equity Share Capital |
15.57 |
15.52 |
15.48 |
15.46 |
15.46 |
|
| Total Share Capital |
15.57 |
15.52 |
15.48 |
15.46 |
15.46 |
|
| Reserves and Surplus |
3,361.63 |
2,870.74 |
2,305.38 |
2,025.56 |
1,791.00 |
|
| Total Reserves and Surplus |
3,361.63 |
2,870.74 |
2,305.38 |
2,025.56 |
1,791.00 |
|
| Total Shareholders Funds |
3,377.19 |
2,886.26 |
2,442.45 |
2,103.67 |
1,806.46 |
|
| NON-CURRENT LIABILITIES |
|
|
|
|
|
|
| Long Term Borrowings |
0.00 |
23.64 |
383.22 |
0.00 |
0.00 |
|
| Deferred Tax Liabilities [Net] |
186.25 |
154.54 |
106.58 |
51.92 |
63.77 |
|
| Other Long Term Liabilities |
7.82 |
9.81 |
15.23 |
21.92 |
10.07 |
|
| Long Term Provisions |
22.19 |
18.33 |
14.61 |
13.22 |
12.57 |
|
| Total Non-Current Liabilities |
216.26 |
206.32 |
519.64 |
87.06 |
86.41 |
|
| CURRENT LIABILITIES |
|
|
|
|
|
|
| Short Term Borrowings |
0.00 |
318.16 |
143.71 |
26.32 |
26.43 |
|
| Trade Payables |
384.58 |
331.65 |
221.71 |
196.24 |
164.02 |
|
| Other Current Liabilities |
140.67 |
124.55 |
104.27 |
83.50 |
92.49 |
|
| Short Term Provisions |
59.18 |
46.70 |
38.34 |
41.29 |
24.62 |
|
| Total Current Liabilities |
584.44 |
821.06 |
508.03 |
347.34 |
307.56 |
|
| Total Capital And Liabilities |
4,177.90 |
3,913.64 |
3,470.15 |
2,538.07 |
2,200.43 |
|
| ASSETS |
|
|
|
|
|
|
| NON-CURRENT ASSETS |
|
|
|
|
|
|
| Tangible Assets |
606.60 |
567.23 |
526.63 |
548.54 |
542.27 |
|
| Intangible Assets |
1,276.69 |
1,358.19 |
1,295.03 |
655.13 |
22.33 |
|
| Capital Work-In-Progress |
45.96 |
63.32 |
44.41 |
13.91 |
25.57 |
|
| Other Assets |
0.00 |
0.00 |
0.00 |
0.00 |
0.00 |
|
| Fixed Assets |
1,944.99 |
2,001.48 |
1,876.81 |
1,222.34 |
590.17 |
|
| Non-Current Investments |
170.86 |
166.58 |
146.75 |
145.69 |
145.88 |
|
| Deferred Tax Assets [Net] |
0.00 |
0.00 |
0.00 |
0.00 |
0.00 |
|
| Long Term Loans And Advances |
0.35 |
0.58 |
0.68 |
0.74 |
5.19 |
|
| Other Non-Current Assets |
283.04 |
29.59 |
47.60 |
16.98 |
1.25 |
|
| Total Non-Current Assets |
2,399.24 |
2,198.24 |
2,071.85 |
1,385.75 |
742.49 |
|
| CURRENT ASSETS |
|
|
|
|
|
|
| Current Investments |
317.11 |
364.65 |
192.18 |
0.00 |
664.97 |
|
| Inventories |
471.64 |
461.20 |
386.95 |
349.78 |
278.91 |
|
| Trade Receivables |
768.09 |
624.78 |
523.58 |
518.05 |
374.11 |
|
| Cash And Cash Equivalents |
90.57 |
63.70 |
55.76 |
39.67 |
26.43 |
|
| Short Term Loans And Advances |
0.55 |
0.70 |
0.77 |
0.75 |
1.65 |
|
| OtherCurrentAssets |
130.71 |
200.38 |
239.06 |
244.06 |
111.87 |
|
| Total Current Assets |
1,778.65 |
1,715.40 |
1,398.30 |
1,152.31 |
1,457.94 |
|
| Total Assets |
4,177.90 |
3,913.64 |
3,470.15 |
2,538.07 |
2,200.43 |
|
| OTHER ADDITIONAL INFORMATION |
|
|
|
|
|
|
| CONTINGENT LIABILITIES, COMMITMENTS |
|
|
|
|
|
|
| Contingent Liabilities |
1,165.42 |
1,110.90 |
148.86 |
68.13 |
117.00 |
|
| CIF VALUE OF IMPORTS |
|
|
|
|
|
|
| Raw Materials |
0.00 |
0.00 |
0.00 |
0.00 |
0.00 |
|
| Stores, Spares And Loose Tools |
0.00 |
0.00 |
0.00 |
0.00 |
0.00 |
|
| Trade/Other Goods |
0.00 |
0.00 |
0.00 |
0.00 |
0.00 |
|
| Capital Goods |
0.00 |
0.00 |
0.00 |
0.00 |
0.00 |
|
| EXPENDITURE IN FOREIGN EXCHANGE |
|
|
|
|
|
|
| Expenditure In Foreign Currency |
375.18 |
381.00 |
549.99 |
214.26 |
179.21 |
|
| REMITTANCES IN FOREIGN CURRENCIES FOR DIVIDENDS |
|
|
|
|
|
|
| Dividend Remittance In Foreign Currency |
-- |
-- |
-- |
-- |
-- |
|
| EARNINGS IN FOREIGN EXCHANGE |
|
|
|
|
|
|
| FOB Value Of Goods |
-- |
-- |
-- |
-- |
-- |
|
| Other Earnings |
1,302.39 |
1,315.08 |
1,278.42 |
894.33 |
908.22 |
|
| BONUS DETAILS |
|
|
|
|
|
|
| Bonus Equity Share Capital |
8.46 |
8.46 |
8.46 |
8.46 |
8.46 |
|
| NON-CURRENT INVESTMENTS |
|
|
|
|
|
|
| Non-Current Investments Quoted Market Value |
-- |
-- |
-- |
-- |
-- |
|
| Non-Current Investments Unquoted Book Value |
170.86 |
166.58 |
146.75 |
145.69 |
145.88 |
|
| CURRENT INVESTMENTS |
|
|
|
|
|
|
| Current Investments Quoted Market Value |
317.11 |
364.65 |
-- |
-- |
664.97 |
|
| Current Investments Unquoted Book Value |
-- |
-- |
-- |
-- |
-- |
|
Source : Dion Global Solutions Limited
